Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156877 Receptor for interleukin-4; has molecular weight of about 200,000 daltons; antitumor agents; immunosuppressants; antibodies
12/05/2000US6156795 Peptides that stimulate the appetite
12/05/2000US6156771 Method for alleviation of lower gastrointestinal disorders in a human patient
12/05/2000US6156768 Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/05/2000US6156754 Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage)
12/05/2000US6156738 Controlling nighttime blood sugar level
12/05/2000US6156736 Gene transcription and ionizing radiation: methods and compositions
12/05/2000US6156734 Cardiovascular disorders
12/05/2000US6156733 Use of leukemia inhibitory factor and endothelin antagonists
12/05/2000US6156732 A (di, tri or tetra)oligopeptide
12/05/2000US6156731 Enteric overcoating
12/05/2000US6156730 Anti-fungal peptides
12/05/2000US6156729 Leukemia inhibitory factor for use in modulating inflammation and pain
12/05/2000US6156728 Administering fibroblast growth factor
12/05/2000US6156727 Synthetic peptide; anticholesterol agents
12/05/2000US6156726 Voltage-gated calcium channel antagonist and method
12/05/2000US6156725 Drug for the treatment of cancer
12/05/2000US6156724 Uses of didemnins as immunomodulating agents
12/05/2000US6156572 Three dimensional high water content matrix having at least one cellular adhesion molecule covalently immobilized and homogeneously dispersed; facilitates tissue regeneration or replacement
12/05/2000US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders
12/05/2000US6156557 For use as a protein decomposing agent, a cleansing agent, a detergent, a hair decomposing agent, and an agent for inhibiting blockage of drains caused by protein build-up
12/05/2000US6156556 Flea protease proteins, nucleic acid molecules, and uses thereof
12/05/2000US6156551 Activated mutants of SH2-domain-containing protein tyrosine phosphatases and methods of use thereof
12/05/2000US6156542 Preparing raw cytokines; purifying leukocytes, culture leukocytes, adjust heat, incubate with cytokine, incubate with sendai virus, lower heat, incubate with sendai virus and separate leukocytes from cytokines
12/05/2000US6156541 Compositions and methods for catalyzing hydrolysis of HIV gp120
12/05/2000US6156537 Phospho-N-acetylmuramoyl-pentapeptide transferase of Streptococcus pneumoniae
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000US6156516 Method for screening substance inhibiting activation of NF-κB
12/05/2000US6156513 Rna oligomer which binds to collagen gene promoter to form a triplex; antifibrotic agents for pathological fibrosis such as restenosis, atherosclerosis, liver cirrhosis, lung fibrosis, and skin fibrosis found in scleroderma
12/05/2000US6156500 Methods for the treatment and diagnosis of cardiovascular disease
12/05/2000US6156496 Suppressing microorganism propagation in eukaryotic cell; administering a blocking agent to cells to prevent suppression of kinase activity
12/05/2000US6156495 Kit for detecting the presence of microorganism antigen in humans; for the development of vaccines against viral diseases
12/05/2000US6156368 Lactose-containing food composition for infants
12/05/2000US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications
12/05/2000US6156345 Crosslinkable macromers bearing initiator groups
12/05/2000US6156331 Sustained delivery of an active agent using an implantable system
12/05/2000US6156322 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
12/05/2000US6156321 Tissue factor methods and compositions for coagulation and tumor treatment
12/05/2000US6156319 Polypeptide
12/05/2000US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
12/05/2000US6156315 Cardiovascular disorders
12/05/2000US6156314 Monoclonal antibodies
12/05/2000US6156313 Human monoclonal antibodies to herpes simplex virus and methods therefor
12/05/2000US6156311 Reducing catabolism
12/05/2000US6156310 Isolated polypeptide
12/05/2000US6156305 Implanted tumor cells for the prevention and treatment of cancer
12/05/2000US6156302 Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
12/05/2000US6156301 Genetric engineered interleukin
12/05/2000US6156300 Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
12/05/2000US6155266 Stimulating the production of natural killer cells to destroy tumor cells by administering interferons and a histamine receptors agonist
12/05/2000CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
12/05/2000CA2098921C Angiogenic peptides
12/05/2000CA2036089C Prolonged release microcapsules
12/05/2000CA1341151C Osmotic agents form peritoneal dialysis
12/05/2000CA1341150C Amplifying the expression of recombinant dna products
12/05/2000CA1341149C Insulin receptor
12/04/2000CA2309395A1 Methods for preventing and treating alzheimer's disease
12/03/2000CA2308842A1 Amelioration of peyronie's disease
11/2000
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000071753A2 Diagnostics and therapeutics for restenosis
11/30/2000WO2000071751A1 Diabetes gene
11/30/2000WO2000071740A1 High specificity hairpin antisense oligonucleotides
11/30/2000WO2000071734A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000WO2000071728A1 Recombinant bacterial phytases and uses thereof
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071719A1 Interleukin-1 hy2 materials and methods
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071716A2 Vascular endothelial growth factor dimers
11/30/2000WO2000071715A1 Fibroblast growth factor 11
11/30/2000WO2000071714A2 Methods of reducing factor viii clearance and compositions therefor
11/30/2000WO2000071713A1 Vascular endothelial growth factor variants
11/30/2000WO2000071708A2 Use of ef-ts for treating smooth muscle cell hyperplasia
11/30/2000WO2000071706A1 ANTISENSE TO c-myc FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
11/30/2000WO2000071703A2 Inhibition of histone deacetylase
11/30/2000WO2000071679A2 Human oxidoreductase proteins
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071583A1 Murine interleukin-1 homologue, il-1h3
11/30/2000WO2000071582A1 Fibroblast growth factor 14
11/30/2000WO2000071581A1 Novel polypeptide
11/30/2000WO2000071578A2 New polypeptides and their use for the rescue of fusion defective virus or retrovirus glycoproteins
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071576A2 Adenovirus vectors encoding brain natriuretic peptide
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071573A2 Immunogenic peptides derived from mage and the use thereof
11/30/2000WO2000071571A2 Fap-activated anti-tumor compounds
11/30/2000WO2000071567A2 Fibroblast growth factor 13
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000WO2000071556A1 Prodrug activation using catalytic antibodies
11/30/2000WO2000071555A2 509rr
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071188A1 Device and method for infusion of small molecule insulin mimetic materials
11/30/2000WO2000071164A1 Inhibition of gastric acid production and/or secretion
11/30/2000WO2000071161A1 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferative drugs
11/30/2000WO2000071153A2 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors
11/30/2000WO2000071152A1 Fibroblast growth factor 10
11/30/2000WO2000071151A1 Liver function controlling agents
1 ... 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 ... 3163